Antiarrhythmic drugs for ventricular tachycardia and evolving technology for coronary and valvular surgery Valentin Fuster Editor's Commentary Pages: 257 - 258
Redefining the role of antiarrhythmic drugs in the management of ventricular arrhythmias Davendra Mehta Clinical Trials Review Pages: 265 - 267
Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete? Ryan CooleyMasood AkhtarJasbir Sra OriginalPaper Pages: 268 - 273
Beta-blockers and amiodarone for the primary prevention of sudden cardiac death Olivier FrankenbergerJonathan S. Steinber OriginalPaper Pages: 274 - 281
Interactions of antiarrhythmic drugs with implantable defibrillator therapy for atrial and ventricular tachyarrhythmias Ryszard B. KrolSanjeev SaksenaAtul Prakash OriginalPaper Pages: 282 - 288
Proarrhythmia, a serious complication of antiarrhythmic drugs Philip J. Podrid OriginalPaper Pages: 289 - 296
The role of antiarrhythmic therapy in the management of nonsustained ventricular tachycardia J. Anthony Gomes OriginalPaper Pages: 297 - 301
The impact of recent ion channel science on the development and use of antiarrhythmic drugs Marie-Noelle S. Langan OriginalPaper Pages: 302 - 307
New minimal access approaches to multivessel coronary artery bypass grafting without pump Valavanur A. SubramanianNilesh Patel Clinical Trials Review Pages: 311 - 312
Multivessel corornary bypass grafting without cardiopulmonary support Todd M. DeweyMichael J. Mack OriginalPaper Pages: 313 - 317
Is minimally invasive heart valve surgery a paradigm for the future? A. Mar GillinovMichael K. BanburyDelos M. Cosgrove OriginalPaper Pages: 318 - 322
Left internal mammary artery grafting to left anterior descending coronary artery by minimally invasive direct coronary artery bypass approach Anno Diegeler OriginalPaper Pages: 323 - 330
Multivessel coronary bypass grafting with minimal access using cardiopulmonary bypass Mark GrohEugene A. Grossi OriginalPaper Pages: 331 - 334
